Modular Medical boosts authorized share count

Modular Medical, Inc. reported that shareholders approved a charter amendment increasing the company’s authorized common stock from 100,000,000 to 250,000,000 shares.

Rhea-AI Filing Summary

Modular Medical, Inc. reported that shareholders approved a charter amendment increasing the company’s authorized common stock from 100,000,000 to 250,000,000 shares. This amendment was filed with the Nevada secretary of state on January 23, 2026, and reflects shareholder approval at the 2026 annual meeting.

At the annual meeting, a quorum representing approximately 69% of the outstanding common shares entitled to vote was present in person, virtually, or by proxy. All nominated directors, including Duane DeSisto, Paul DiPerna, and other candidates listed, were elected to serve until the next annual meeting. The filing also shows that shareholders approved each of the six proposals presented, based on the reported vote totals.

Insights

Corporate actions analyst

Share authorization expanded; all annual meeting items passed.

Modular Medical obtained shareholder approval to increase its authorized common stock from 100,000,000 to 250,000,000 shares and has already filed the charter amendment with Nevada authorities. This change does not itself issue new shares, but it permits the company to issue more stock in the future if it chooses.

The annual meeting appears orderly, with a quorum representing about 69% of eligible common shares and all director nominees elected. All six proposals received sufficient “For” votes to pass, indicating broad support for the board’s agenda in this context.

8-K Event Classification

4 items: 3.03, 5.03, 5.07, 9.01

4 items

Item 3.03 Material Modification to Rights of Security Holders Securities

A change was made that materially affects the rights of existing shareholders (e.g., dividend rights, voting rights).

Item 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year Governance

The company amended its charter documents, bylaws, or changed its fiscal year.

Item 5.07 Submission of Matters to a Vote of Security Holders Governance

Results of a shareholder vote on proposals at an annual or special meeting.

Item 9.01 Financial Statements and Exhibits Exhibits

Financial statements, pro forma financial information, or exhibit attachments filed with this report.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Modular Medical, Inc. (MODD) change in its capital structure?

The company amended its Amended and Restated Articles of Incorporation to increase authorized common stock from 100,000,000 to 250,000,000 shares, as reflected in a charter amendment filed in Nevada on January 23, 2026.

Who approved the increase in authorized shares for MODD?

Shareholders of Modular Medical approved the charter amendment to increase authorized common stock at the fiscal 2026 annual meeting held on January 23, 2026.

Was there a quorum at Modular Medical’s 2026 annual meeting?

Yes. The company reports that a quorum for conducting business was present, with approximately 69% of outstanding common shares entitled to vote represented in person, virtually, or by proxy.

Were Modular Medical’s director nominees elected at the 2026 annual meeting?

Yes. All listed director candidates, including Duane DeSisto, Paul DiPerna, Steven Felsher, Morgan Frank, Jeffrey Goldberg, Philip Sheibley, Carmen Volkart, and Ellen O’Connor Vos, were elected to serve until the next annual meeting and until their successors are qualified or they resign or are removed.

How many proposals did Modular Medical shareholders vote on, and what was the outcome?

Shareholders voted on six proposals described in the company’s definitive proxy statement dated January 8, 2026. Based on the reported vote tallies, each of the six proposals was approved.

What exhibits were included with this Modular Medical 8-K filing?

The filing includes Exhibit 3.1, which is the Certificate of Amendment to the Amended and Restated Articles of Incorporation filed in Nevada on January 23, 2026, and Exhibit 104, the cover page Inline XBRL data file.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding 8-K Material Events →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 01/23/2026 - 05:00 PM EST Learn about SEC filing dates

false --03-31 0001074871 0001074871 2026-01-23 2026-01-23 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event Reported): January 23, 2026

MODULAR MEDICAL, INC.

(Exact Name of Registrant as Specified in Charter)

001-41277

(Commission File Number)

Nevada		87-0620495
(State or Other Jurisdiction of Incorporation)		(I.R.S. Employer Identification Number)

10740 Thornmint Road

San Diego, California 92127

(Address of principal executive offices, with zip code)

(858) 800-3500

(Registrant’s telephone number, including area code)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class		Trading Symbol(s)		Name of each exchange on which registered
Common Stock		MODD		The Nasdaq Stock Market LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR§230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 3.03 Material Modification to Rights of Security Holders.

To the extent required by Item 3.03 of Form 8-K, the information regarding the increase in authorized shares contained in Item 5.03 of this Current Report on Form 8-K is incorporated by reference herein.

Item 5.03. Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year.

On January 23, 2026, Modular Medical, Inc. (the “Company”) filed a certificate of amendment to its Amended and Restated Articles of Incorporation (as amended, the “Amended and Restated Certificate of Incorporation”) (the “Charter Amendment”), with the secretary of state of the state of Nevada to increase the Company’s authorized shares of common stock from 100,000,000 to 250,000,000. The Charter Amendment was approved by the shareholders at the Company’s fiscal 2026 annual meeting of shareholders held on January 23, 2026 (the “Annual Meeting”), as disclosed in Item 5.07 of this Current Report on Form 8-K. The foregoing description of the Charter Amendment is not complete and is subject to, and qualified in its entirety by, the complete text of the Charter Amendment, which is filed as Exhibit 3.1 to this Current Report on Form 8-K, and incorporated by reference herein. 

Item 5.07 Submission of Matters to a Vote of Security Holders.

On January 23, 2026, the Company held the Annual Meeting, and a quorum for the transaction of business was present in person virtually or represented by proxy, which represented approximately 69% of the Company’s outstanding shares of common stock entitled to vote at the Annual Meeting. The Company’s shareholders voted on six proposals, which are described in more detail in the Company’s definitive proxy statement filed with the Securities and Exchange Commission on January 8, 2026.

Summarized below are the final voting results for each proposal submitted to a vote of the shareholders at the Annual Meeting.

● Proposal 1 - Election of directors to serve until the next annual meeting of shareholders.

		For				Against				Abstention/ Withheld				Broker Non-Vote
Duane DeSisto			41,231,246				439,190				92,492				12,223,897
Paul DiPerna			37,167,499				4,539,652				55,777				12,223,897
Steven Felsher			39,752,504				1,926,927				83,497				12,223,897
Morgan Frank			39,094,222				2,586,244				82,462				12,223,897
Jeffrey Goldberg			41,526,479				153,683				82,766				12,223,897
Philip Sheibley			39,769,330				1,911,136				82,462				12,223,897
Carmen Volkart			41,376,098				304,385				82,445				12,223,897
Ellen O’Connor Vos			37,561,568				4,091,776				109,584				12,223,897

All of the foregoing candidates were elected to serve as directors until the next annual meeting of shareholders and until the election and qualification of her or his successor or earlier resignation or removal.

● Proposal 2 – Amendment of the Amended and Restated Certificate of Incorporation to effect a reverse stock split of the Company’s common stock at a ratio determined by the board of directors within a specified range, without reducing the authorized number of shares of the Company’s common stock, to be effected in the sole discretion of the board of directors at any time within one year of the date of the Annual Meeting without further approval or authorization of the shareholders

For			Against		Abstain		Broker Non-Vote
	50,603,334		3,373,598		9,893		-

The foregoing proposal was approved.

● Proposal 3 – Amendment of the Amended and Restated Certificate of Incorporation to increase the number of authorized shares of common stock from 100,000,000 shares to 250,000,000 shares.

For		Against		Abstain		Broker Non-Vote
46,750,908		5,042,356		2,193,561		-

The foregoing proposal was approved.

1

● Proposal 4 – Amendment of the Amended and Restated 2017 Equity Incentive Plan, as amended, to increase the number of shares currently reserved for issuance thereunder by 3,000,000 shares.

For		Against		Abstain		Broker Non-Vote
35,384,680		5,800,168		578,080		12,223,987

The foregoing proposal was approved.

● Proposal 5 – Approval, on a non-binding advisory basis, of the compensation of the named executive officers.

For		Against		Abstain		Broker Non-Vote
37,856,002		3,276,127		630,799		12,223,897

The foregoing proposal was approved.

● Proposal 6 – Ratification of the audit committee’s appointment of Farber Hass Hurley LLP as independent registered public accounting firm for the fiscal year ending March 31, 2026.

For		Against		Abstain		Broker Non-Vote
53,269,234		86,531		631,060		-

The foregoing proposal was approved.

2

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits.

Exhibit Number		Exhibit Description
3.1		Certificate of Amendment to Amended and Restated Articles of Incorporation of Modular Medical, Inc., filed with the Secretary of State of the State of Nevada on January 23, 2026
104		Cover Page Interactive Data File (embedded within the Inline XBRL document)

3

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

	MODULAR MEDICAL, INC.
Date: January 23, 2026	By:	/s/ James Besser
		James Besser Chief Executive Officer

4